All National Institutes of Health articles
-
NewsRisk of long COVID in kids doubles after second infection
Children and adolescents were twice as likely to experience long COVID after catching COVID for the second time, compared to their peers with a single previous infection, results running counter to the popular perceptions that COVID in children is ‘mild’.
-
OpinionIt’s game over for dangerous Gain of Function research
The Trump adminstration has signed an Executive Order halting federal gain of function research on microbes - but does it throw the baby out with the bathwater? Virologist Simon Wain-Hobson, Emeritus Professor with the Pasteur Institute, Paris, gives his take.
-
NewsTecovirimat is safe but ineffective as treatment for clade II mpox
The antiviral drug tecovrimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve pain control among adults in an international clinical trial.
-
NewsResearch identifies key antibodies for development of broadly protective norovirus vaccine
A new study identifies powerful antibodies capable of neutralizing a wide range of norovirus strains. The finding could lead to the design of broadly effective norovirus vaccine, as well as the development of new therapeutic antibodies.
-
NewsLonger breastfeeding linked to blood-pressure lowering effects of certain infant gut bacteria
An observational study has found that infants who had more diverse bacteria in their gut had lower childhood blood pressure, and this protective association was stronger if they were breastfed for at least six months.
-
NewsStudy finds cases of ME/CFS increase following SARS-CoV-2
New findings suggest that infection with SARS-CoV-2, the virus that causes COVID-19, may be associated with an increase in the number of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) cases.
-
NewsResearchers discover novel class of anti-malaria antibodies
A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new prevention methods. The most potent of the new antibodies was found to provide protection against malaria parasites in an animal model.
-
NewsPeat-bog fungi produce substances that kill tuberculosis-causing bacteria
An analysis of fungi collected from peat bogs has identified several species that produce substances toxic to the bacterium that causes the human disease tuberculosis.
-
NewsTrial of rectal microbicide for HIV prevention begins in US
A clinical trial has launched to examine the safety and acceptability of a novel rectal HIV microbicide douche containing the antiretroviral drug tenofovir.
-
NewsEmergency department screening more than doubles detection of syphilis cases
Providing optional syphilis tests to most people seeking care at a large emergency department led to a dramatic increase in syphilis screening and diagnosis, according to a study of nearly 300,000 emergency department encounters in Chicago.
-
NewsLong Covid continues to evade diagnosis
A national cohort study of adult US participants with and without prior SARS-CoV-2 infection found that there are no objective tests to accurately diagnose post-acute sequelae of SARS-CoV-2 infection (PASC), also known as Long Covid.
-
NewsResearchers receive 9.5 million grant to study relationship between polyphenol intake, Alzheimer’s and the brain-gut-microbiome system
UCLA Health researchers, in collaboration with researchers from the Republic of Ireland and Northern Ireland, have received a $9.5 million award to study the effects of polyphenols on cognitive health and the brain-gut microbiome system.
-
NewsNew findings may fix the replicability crisis in microbiome research
Scientists report that daily fluctuations in the gut alter the microbiome so significantly that different bugs populate it in the morning and in the evening.
-
News$1.3 million fund helps to introduce high school students to virus surveillance
The Icahn School of Medicine at Mount Sinai has received more than $1.3 million from the National Institute of General Medical Sciences of the National Institutes of Health (NIH) to expand the New York City Virus Hunters program.
-
NewsHypervirulent bacteria emerging in healthy people
New ’hypervirulent’ strains of the bacterium Klebsiella pneumoniae have emerged in healthy people in community settings, prompting researchers to investigate how the human immune system defends against infection.
-
NewsProbiotic markedly reduces staph colonisation in phase 2 trial
A approach to control Staphylococcus aureus bacterial colonization in people—using a probiotic instead of antibiotics—was found to be safe and highly effective in a Phase 2 clinical trial.
-
NewsExperimental monoclonal antibodies take the fight to Epstein-Barr virus
Researchers have discovered a panel of investigational monoclonal antibodies (mAbs) targeting different sites of the Epstein-Barr virus (EBV) blocked infection when tested in human cells in a laboratory setting.